Infectious diseases continue to pose a substantial threat to the operational capacity of military forces. Protecting Our Forces reviews the process by which the U.S. military acquires vaccines to protect its warfighters from natural infectious disease threats. The committee found that poorly aligned acquisition processes and an inadequate commitment of financial resources within the Department of Defense vaccine acquisition process a " rather than uncleared scientific or technological hurdles a " contribute to the unavailability of some vaccines that could protect military personnel and, implicitly, the welfare and security of the nation. Protecting Our Forces outlines ways in which DoD might strengthen its acquisition process and improve vaccine availability. Recommendations, which include combining all DoD vaccine acquisition responsibilities under a single DoD authority, cover four broad aspects of the acquisition process: (1) organization, authority, and responsibility; (2) program and budget; (3)manufacturing; (4) and the regulatory status of special-use vaccines.
Stanley M. Lemon, Susan Thaul, Salem Fisseha and Heather C. O'Maonaigh, Editors, Committee on a Strategy for Minimizing the Impact of Naturally Occurring Infectious Diseases of Military Importance: Vaccine Issues in the U.S. Military
1 Front Matter; 2 Executive Summary; 3 1 Introduction and History; 4 2 Resources, Responsibilities, and Dynamics in the Military's Vaccine Mission; 5 3 Current Status of Vaccines for Military Personnel; 6 4 Recommendations with Accompanying Analysis of Limitations Imposed by Current Department of Defense Structure for Managing Acquisition of Vaccines Against Infectious Diseases; 7 References; 8 Appendix A: Reprint of the commitee's November 2000 Interim Report, Urgent Attention Needed to Restore Lapsed Adenovirus Vaccine Availability: A Letter Report,; 9 Appendix B: Open Meeting Agendas; 10 Appendix C: Committee and Staff Biographies
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, Medical Follow-up Agency, Committee to Study the Mortality of Military Personnel Present at Atmospheric Tests of Nuclear Weapons, Heather O'Maonaigh, Harriet Crawford, William F. Page, Susan Thaul
Institute of Medicine, Medical Follow-Up Agency, Committee to Review the Department of Defense Global Emerging Infections Surveillance and Response System, Richard N. Miller, Heather C. O'Maonaigh, Philip S. Brachman
Institute of Medicine, Medical Follow-Up Agency, and Chemicals in U.S. Military Forces Committee to Study the Interactions of Drugs, Biologics, Susan Thaul, William F. Page, Robert G. Petersdorf
Institute of Medicine, Medical Follow-up Agency, Committee on Noise-Induced Hearing Loss and Tinnitus Associated with Military Service from World War II to the Present, Jane S. Durch, Lois M. Joellenbeck, Larry E. Humes
National Research Council, Institute of Medicine, Board on Life Sciences, Medical Follow-up Agency, and Acquisition of Medical Countermeasures Against Biological Warfare Agents Committee on Accelerating the Research, Development, Leslie Z. Benet, Jane S. Durch, Lois M. Joellenbeck